214 related articles for article (PubMed ID: 15113584)
1. Bupivacaine containing dry emulsion can prolong epidural anesthetic effects in rabbits.
Dollo G; Le Corre P; Chevanne F; Le Verge R
Eur J Pharm Sci; 2004 May; 22(1):63-70. PubMed ID: 15113584
[TBL] [Abstract][Full Text] [Related]
2. Prolongation of epidural bupivacaine effects with hyaluronic acid in rabbits.
Dollo G; Malinovsky JM; Péron A; Chevanne F; Pinaud M; Le Verge R; Le Corre P
Int J Pharm; 2004 Mar; 272(1-2):109-19. PubMed ID: 15019074
[TBL] [Abstract][Full Text] [Related]
3. [Biopharmaceutics of local anesthetic-cyclodextrin complexes following loco-regional administration].
Dollo G; Le Corre P; Fréville JC; Chevanne F; Leverge R
Ann Pharm Fr; 2000 Dec; 58(6):425-32. PubMed ID: 11148378
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of epidural anaesthesia in dogs with bupivacaine in a lipid emulsion.
Franquelo C; Toledo A; Manubens J; Cristòfol C; Valladares JE; Arboix M
Vet Rec; 2000 Oct; 147(17):477-80. PubMed ID: 11093399
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of nerve and epidural anesthetic blockade by bupivacaine in a lipid emulsion.
Lázaro JJ; Franquelo C; Navarro X; Castellano B; Verdú E; Cristòfol C; Arboix M
Anesth Analg; 1999 Jul; 89(1):121-7. PubMed ID: 10389789
[TBL] [Abstract][Full Text] [Related]
6. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic-pharmacodynamic modeling of epidural anesthesia.
Olofsen E; Burm AG; Simon MJ; Veering BT; van Kleef JW; Dahan A
Anesthesiology; 2008 Oct; 109(4):664-74. PubMed ID: 18813046
[TBL] [Abstract][Full Text] [Related]
8. Emulsion formulations of testosterone for nasal administration.
Ko KT; Needham TE; Zia H
J Microencapsul; 1998; 15(2):197-205. PubMed ID: 9532525
[TBL] [Abstract][Full Text] [Related]
9. In vivo evaluation of tablets and capsules containing spray-dried o/w-emulsions for oral delivery of poorly soluble drugs.
Hansen T; Holm P; Rohde M; Schultz K
Int J Pharm; 2005 Apr; 293(1-2):203-11. PubMed ID: 15778058
[TBL] [Abstract][Full Text] [Related]
10. Bupivacaine disposition and pharmacologic effects after intravenous and epidural administrations in dogs.
Franquelo C; Toledo A; Manubens J; Cristòfol C; Arboix M
Am J Vet Res; 1995 Aug; 56(8):1087-91. PubMed ID: 8533982
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo entrapment of bupivacaine by lipid dispersions.
Litonius E; Lokajova J; Yohannes G; Neuvonen PJ; Holopainen JM; Rosenberg PH; Wiedmer SK
J Chromatogr A; 2012 Sep; 1254():125-31. PubMed ID: 22832037
[TBL] [Abstract][Full Text] [Related]
12. High-dose bupivacaine remotely loaded into multivesicular liposomes demonstrates slow drug release without systemic toxic plasma concentrations after subcutaneous administration in humans.
Davidson EM; Barenholz Y; Cohen R; Haroutiunian S; Kagan L; Ginosar Y
Anesth Analg; 2010 Apr; 110(4):1018-23. PubMed ID: 20357145
[TBL] [Abstract][Full Text] [Related]
13. The "inverted cup" -- a novel in vitro release technique for drugs in lipid formulations.
Söderberg L; Dyhre H; Roth B; Björkman S
J Control Release; 2006 Jun; 113(1):80-8. PubMed ID: 16697069
[TBL] [Abstract][Full Text] [Related]
14. Micronized emulsion for controlled release of physostigmine after oral administration. Part II. Release characteristics and pharmacological evaluation.
Benita S; Friedman D; Pathak YV; Kleinstern J
Drug Des Deliv; 1989 Mar; 4(2):143-53. PubMed ID: 2765107
[TBL] [Abstract][Full Text] [Related]
15. Extended duration local anesthetic agent in a rat paw model.
Ickowicz DE; Golovanevski L; Domb AJ; Weiniger CF
Int J Pharm; 2014 Jul; 468(1-2):152-7. PubMed ID: 24726301
[TBL] [Abstract][Full Text] [Related]
16. Polymeric alginate nanoparticles containing the local anesthetic bupivacaine.
Grillo R; de Melo NF; de Araújo DR; de Paula E; Rosa AH; Fraceto LF
J Drug Target; 2010 Nov; 18(9):688-99. PubMed ID: 20196632
[TBL] [Abstract][Full Text] [Related]
17. [A clinical trial of the use of 2 forms of bupivacaine hydrochloride (Anecaine and Marcaine) for epidural anesthesia].
Kozlov SP; Vashchinskaia TV; Svetlov VA
Anesteziol Reanimatol; 1999; (5):69-71. PubMed ID: 10560158
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin.
Ahmed IS; Aboul-Einien MH
Eur J Pharm Sci; 2007 Sep; 32(1):58-68. PubMed ID: 17628451
[TBL] [Abstract][Full Text] [Related]
19. Is there a need for chloroprocaine 3% and bupivacaine 0.75%?
Covino BG
Acta Anaesthesiol Belg; 1988; 39(3):151-7. PubMed ID: 3057787
[TBL] [Abstract][Full Text] [Related]
20. The influence of epidural volume extension on spinal block with hyperbaric or plain bupivacaine for Caesarean delivery.
Kucukguclu S; Unlugenc H; Gunenc F; Kuvaki B; Gokmen N; Gunasti S; Guclu S; Yilmaz F; Isik G
Eur J Anaesthesiol; 2008 Apr; 25(4):307-13. PubMed ID: 17888192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
